用高效调节器疗法治疗囊性纤维化患者的怀孕
Jennifer L Goralski1, Asha N Talati, Emily E Hardisty
1Division of Pulmonary and Critical Care Medicine, the Division of Pediatric Pulmonology, and the Division of Maternal Fetal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
患有囊性纤维化 (CF) 的人因新疗法而越来越多地怀孕. 然而,这些高效的调节器疗法在怀孕期间和胎儿的安全性需要进一步调查.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高效调节器疗法的近期进展改善了囊性纤维化 (CF) 患者的健康状况.
- 由于改善了健康结果,越来越多的CF患者正在考虑怀孕.
- 怀孕期间高效调制剂治疗的安全性和对胎儿发育的影响尚未得到充分证实.
研究的目的:
- 审查当前对高效调节器疗法在患有CF的孕妇中使用的理解.
- 识别与孕产妇和胎儿结局有关的潜在风险和知识差距.
- 强调多学科辅导对患有CF的生殖年龄人群的重要性.
主要方法:
- 对高效调节器治疗和怀孕现有研究的文献综述.
- 对有关母亲健康,胎儿结果和后代发育的数据进行分析.
- 确定需要进一步前性研究的领域.
主要成果:
- 有限的数据表明潜在的风险,包括在停止治疗后母亲健康状况下降以及可能与后代白内障相关.
- 高效的调节器疗法可能会影响新生儿查结果和胎儿的结果,由于胎盘通过.
- 目前的证据不足以充分确定怀孕期间的安全性.
结论:
- 对于考虑怀孕的生殖年龄的CF患者来说,多学科咨询至关重要.
- 需要进行进一步的前性研究,以充分评估高效调节器治疗在孕妇CF患者及其后代的安全性和影响.
- 在怀孕期间治疗CF需要仔细考虑治疗益处与潜在风险.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs for Treatment of Constipation-Predominant IBS
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
